Adaptive and Behavioral Changes in Kynurenine 3-monooxygenase Knockout Mice: Relevance to Psychotic Disorders

BACKGROUND: Kynurenine 3-monooxygenase (KMO) converts kynurenine to 3-hydroxykynurenine, and its inhibition shunts the kynurenine pathway - which is implicated as dysfunctional in various psychiatric disorders - towards enhanced synthesis of kynurenic acid (KYNA), an antagonist of both α7 nicotinic...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Biol Psychiatry
Autori principali: Erhardt, Sophie, Pocivavsek, Ana, Repici, Mariaelena, Liu, Xi-Cong, Imbeault, Sophie, Maddison, Daniel C, Thomas, Marian AR, Smalley, Joshua L, Larsson, Markus K, Muchowski, Paul J, Giorgini, Flaviano, Schwarcz, Robert
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2016
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5812460/
https://ncbi.nlm.nih.gov/pubmed/28187857
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.biopsych.2016.12.011
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi